Evotec’s Pathology team counts three anatomic pathologists, one clinical pathologist and eight histotechnicians, as well as internationally recognised external consultants in the fields. Our pathologists have up to 25 years of experience with a broad skillset in discovery and clinical-enabling pathology techniques and possess internationally recognised qualifications (DACVP/DECVP, MRCPATH, DECLAM qualified pathologists/clinical pathologists). The histology team includes highly specialised and trained histotechnicians.
Evotec Pathology unit is principally dedicated to toxicological pathology for drug development in multiple species (rodents and non-rodents), but it is also involved in supporting investigative studies to target attrition issues, validation and characterisation of animal models, and identification and validation of biomarkers.
GLP and international regulatory standards are applied to all pathology activities in order to meet the requirements for developing drug products worldwide.